Major mental health disorders are some of the most difficult conditions to manage. According to a retrospective analysis in Systematic Reviews, almost 450 million people are affected by mental health disorders worldwide, contributing 14% of the overall global burden of…
For payers and pharmacists, designing an effective adherence program to support patients can be challenging, according to AllazoHealth’s William Grambley, COO, and Dr. Linda Schultz, VP, Clinical and Customer Success. Keeping these tips in mind can help. 1. Design your…
Barriers to medication adherence can take the form of social determinants such as housing, employment and access to pharmacies – and systemic barriers such as pre-approvals, multiple prescriptions and affordability. But psychological barriers also play a major role. Understanding these…
When patients have multiple prescriptions, especially for long term conditions, refill dates often are not aligned and create barriers to adherence. So, pharmacies have been integrating medication synchronization programs into their workflow. Medication synchronization enables patients to fill all their…
Improved understanding about the effect of social determinants of health (SDOH) on population health outcomes have spurred increased innovation from payers. Social determinants of health are the conditions where patients live, learn, work and play. Key SDOH areas include employment,…
Are you responsible for improving your plan’s quality ratings? Learn how to improve your performance on Star and other quality measures. Download our deck and get specific advice for payers on: The influence of population mix on performance Which patients…
Payers, pharmacies and pharmaceutical companies are starting to join providers in recognizing that social determinants of health (SDOH) have a major impact on patient adherence and clinical outcomes. Healthcare organizations now face the challenge of finding ways to analyze and…
Besides being a financial issue for pharmaceutical companies, unfilled prescriptions can lead to poorer health outcomes, drive up overall cost of care, and can have an impact on provider performance under value-based payment models. Pharmaceutical companies often use copay assistance…
What do payers consider as they grapple with the medication access and adherence needs of at-risk patients during the Covid-19 pandemic? Experts at McMann Managed Markets and Syneos Health surveyed their proprietary payer advisory boards to find out. Payers respond…
AllazoHealth, a company that uses artificial intelligence (AI) to help enterprise healthcare companies improve medication adherence and quality outcomes, has released a new study demonstrating the impact of AI on patient adherence indicators. The poster outlining the study was published…